Form 13-F position report

CARDIOL THERAPEUTICS INC

Reported by Boyer Financial Services Inc

CRDL CUSIP 14161Y200 Manager CIK 0002108122

Reported 34,100 shares, up 11,000 (47.6%) from the prior quarter.

Reported value 14.8%; share count 47.6% vs. the prior quarter.

Added
% of reported 13F value 0.03% This manager · Q2 2026
Shares 34,100 Quarter-end amount reported
Reported value $35,805 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 32908
2026-03-31 31185
2026-06-30 35805
2026-09-30 56606

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for CARDIOL THERAPEUTICS INC held by Boyer Financial Services Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 34,100 0 (0.0%) 0.05% $56,606 2026-10-23
Q2 2026 Added 34,100 +11,000 (47.6%) 0.03% $35,805 2026-07-20
Q1 2026 Reduced 23,100 -10,000 (-30.2%) 0.03% $31,185 2026-04-10
Q4 2025 New 33,100 +33,100 (0.0%) 0.03% $32,908 2026-01-30

Who else reported the position

58 managers reported CARDIOL THERAPEUTICS INC for Q2 2026.

Managers reporting CARDIOL THERAPEUTICS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
MMCAP International Inc SPC Added 15,598,560 +246,243 1.4% $16,534,474 19 qtrs
Tejara Capital Ltd Reduced 5,113,822 -16,300 2.23% $5,420,651 15 qtrs
Ikarian Capital LLC Added 3,325,000 +600,000 0.38% $3,524,500 2 qtrs
BOOTHBAY FUND MANAGEMENT LLC Added 975,721 +180,840 0.01% $1,034,264 2 qtrs
CITADEL ADVISORS LLC Reduced 796,529 -23,375 < 0.01% $844,320 4 qtrs
RENAISSANCE TECHNOLOGIES LLC Added 772,837 +543,031 < 0.01% $819,207 2 qtrs
TWO SIGMA INVESTMENTS LP Added 746,937 +212,726 < 0.01% $791,753 4 qtrs
INTEGRITY ALLIANCE LLC Reduced 388,492 -76,533 0.01% $411,802 3 qtrs
MORGAN STANLEY Added 355,030 +104,609 < 0.01% $376,332 9 qtrs
The Goldman Sachs Group Inc Added 333,900 +1,500 < 0.01% $353,934 15 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
July 20, 2026
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
34,100
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.